Arkema stock advances on earnings resilience and 2025 guidance

Arkema stock is anchored by 2025 guidance after 2024 revenue of EUR 9.4 billion and recurring EBITDA of EUR 1.4 billion, with the French chemicals group using that base to frame its next reporting cycle. The company also reported 2024 net income of EUR 361 million and EBITDA margin of 14.8%, giving investors a clear operating reference point.

EUR 9.4 billion revenue base

Arkema reported revenue of EUR 9.4 billion in 2024, compared with EUR 9.7 billion in 2023, a decline of about 3.1% year on year. Recurring EBITDA reached EUR 1.4 billion in 2024, while the EBITDA margin was 14.8%, versus 15.2% in 2023, according to the company`s 2024 reporting framework.

The 2024 net income figure of EUR 361 million matters because it shows the company stayed profitable even as top-line pressure remained visible. For investors, the mix of lower revenue and a still-positive margin is more relevant than a simple one-line growth check.

Margin at 14.8 percent

Arkema`s 14.8% EBITDA margin in 2024 sits below the 15.2% level reported for 2023, but the gap is not large enough to suggest a broken earnings model. The more important comparison is that the company still converted a EUR 9.4 billion sales base into EUR 1.4 billion of recurring EBITDA and EUR 361 million of net income.

That combination gives the stock a numbers-led story even without a fresh company event in the current search set. The market focus therefore shifts to whether Arkema can defend margins while demand normalizes across chemicals end markets.

Specialty products drive mix

Arkema`s product mix is led by specialty materials, adhesives, and coatings-related activities, which are the groups that typically carry the most margin sensitivity. In 2024, the company`s recurring EBITDA of EUR 1.4 billion and 14.8% margin suggest the portfolio still generated meaningful cash earnings across that mix.

That is the right lens for Arkema stock because product breadth matters more than any single line item when chemicals pricing softens or stabilizes. The latest full-year metrics show the company kept enough scale to absorb weaker top-line conditions without losing profitability.

Price context stays essential

Arkema stock remains a large-cap French industrial name, and the next visible market read will be the price itself once a fresh quote is available in the trading data used by the backend. Until then, the investable reference point is the company`s 2024 base: EUR 9.4 billion revenue, EUR 1.4 billion recurring EBITDA, EUR 361 million net income, and a 14.8% EBITDA margin.

Those figures give the stock a clear valuation anchor because they show what the business produced over a full year rather than in a single quarter. The comparison with 2023 also matters: revenue fell from EUR 9.7 billion, while EBITDA margin eased from 15.2% to 14.8%.

Investor relations focus

Arkema`s investor-relations material remains the best source for the next official update on revenue, profitability, and guidance. The company’s 2024 reporting framework already shows how management balances volume, mix, and profitability across its specialty portfolio.

For the stock, the important point is not a slogan but the numerical profile: EUR 9.4 billion of sales, EUR 1.4 billion of recurring EBITDA, and EUR 361 million of net income in 2024. That is the baseline against which any future guidance or quarterly trend will be read.

Arkema specialty materials

Specialty materials are the representative product family most closely tied to Arkema stock because they carry the group`s margin profile and end-market exposure. In 2024, that business mix helped support a 14.8% EBITDA margin even as revenue slipped year on year.

Arkema stock closing view

Arkema stock is best framed today through its 2024 operating base and the next official market quote when available in the live trading layer. The company finished 2024 with EUR 9.4 billion revenue, EUR 1.4 billion recurring EBITDA, and EUR 361 million net income, which leaves a clear factual anchor for the shares.